| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/30/2006 | CA2581341A1 Genetic selection of small molecule modulators of protein-protein interactions |
| 03/30/2006 | CA2581240A1 Rhd and abo genotyping by multiplex pcr |
| 03/30/2006 | CA2581174A1 Fluorescent dye compounds, conjugates and uses thereof |
| 03/30/2006 | CA2581140A1 Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis |
| 03/30/2006 | CA2581133A1 Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin |
| 03/30/2006 | CA2581102A1 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 03/30/2006 | CA2581087A1 Genomic assay |
| 03/30/2006 | CA2580921A1 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 03/30/2006 | CA2580840A1 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 03/30/2006 | CA2580727A1 Compositions and methods for obesity screening using polymorphisms in npy2r |
| 03/30/2006 | CA2580504A1 Enhanced antisense oligonucleotides |
| 03/30/2006 | CA2580494A1 Biomarkers for breast cancer |
| 03/30/2006 | CA2580212A1 Molecular beacons |
| 03/30/2006 | CA2580191A1 Cardiac pressure overload associated genes |
| 03/30/2006 | CA2579825A1 Trivalent metal mediated homogeneous luminescent proximity assay |
| 03/30/2006 | CA2579815A1 Antisense antiviral compound and method for treating ssrna viral infection |
| 03/30/2006 | CA2579741A1 Multiple mode multiplex reaction quenching method |
| 03/30/2006 | CA2579225A1 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 03/30/2006 | CA2578736A1 Strain of lactobacillus acidophilus having analgesic properties in the gastrointestinal system |
| 03/30/2006 | CA2577801A1 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 03/30/2006 | CA2573007A1 Copy choice recombination and uses thereof |
| 03/30/2006 | CA2521582A1 Ionic hydrophilic high molecular weight redox polymers for use in enzymatic electrochemical-based sensors |
| 03/30/2006 | CA2521421A1 C-mycer.tam. induced human neural stem cell lines |
| 03/29/2006 | EP1640722A1 Method of inactivating a blood coagulation factor |
| 03/29/2006 | EP1640721A1 Method of judging the onset of periodontitis |
| 03/29/2006 | EP1640460A1 Method and apparatus for analyzing nucleic acid amplification |
| 03/29/2006 | EP1640459A1 Method of diagnosing cancer and method of judging cancer risk |
| 03/29/2006 | EP1640453A1 Digital cell |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1639514A2 Efficient methods for multibody simulations |
| 03/29/2006 | EP1639356A2 Biosensor and method of making cross-reference to related applications |
| 03/29/2006 | EP1639141A2 Methods for treating lentivirus infections |
| 03/29/2006 | EP1639140A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of sars coronavirus |
| 03/29/2006 | EP1639139A2 Methods for the diagnosis and prognosis of alzheimer's disease |
| 03/29/2006 | EP1639138A2 Specific method of prostate cancer detection based on pca3 gene, and kits therefor |
| 03/29/2006 | EP1639137A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 03/29/2006 | EP1639136A2 Fluorescence-based dna primase assays |
| 03/29/2006 | EP1639135A2 Splice site aflp |
| 03/29/2006 | EP1639134A2 Hmg coenzyme a reductase inhibitors affect the mitochondrial dna content of cells |
| 03/29/2006 | EP1639133A2 Method for detection of mutations in dna |
| 03/29/2006 | EP1639132A2 Oligonucleotide ligation assay by detecting released pyrophosphate |
| 03/29/2006 | EP1639131A1 Method for investigating cytosine methylation in dna sequences by means of triplex-forming oligomers |
| 03/29/2006 | EP1639130A2 Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same |
| 03/29/2006 | EP1639129A2 Markers for lxr activation |
| 03/29/2006 | EP1639128A1 Method for detecting nucleic acids with internal control of the amplification |
| 03/29/2006 | EP1639127A1 Dna chip based genetic typing |
| 03/29/2006 | EP1639126A2 Regulome arrays |
| 03/29/2006 | EP1639125A2 Fluorescence assay for mtp activity |
| 03/29/2006 | EP1639124A2 Method for monitoring reactions in real time |
| 03/29/2006 | EP1639123A1 Improved method for the determination of the presence of an antibiotic in a fluid |
| 03/29/2006 | EP1639122A1 Improved test system for the determination of the presence of an antibiotic in a fluid |
| 03/29/2006 | EP1639119A1 Method for the microbiological isomerisation of alpha-hydroxy carboxylic acids |
| 03/29/2006 | EP1639108A2 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 03/29/2006 | EP1639095A2 Method to increase protein production in culture |
| 03/29/2006 | EP1639093A2 Modified molecular beacons |
| 03/29/2006 | EP1639090A2 Compositions and methods for treating and diagnosing cancer |
| 03/29/2006 | EP1639086A2 Rna interferases and methods of use thereof |
| 03/29/2006 | EP1639085A2 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 03/29/2006 | EP1639079A2 Methods for predicting the course of a malignant disease |
| 03/29/2006 | EP1639000A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/29/2006 | EP1638999A2 Compositions and methods for increasing bone mineralization |
| 03/29/2006 | EP1638996A1 Hiv immunogenic complexes |
| 03/29/2006 | EP1638985A2 Detection of survivin in the biological fluids of cancer patients |
| 03/29/2006 | EP1638983A2 Switchable nucleic acids for diagnostics, screening and molecular electronics |
| 03/29/2006 | EP1638587A2 Contraceptive methods and compositions related to proteasomal interference |
| 03/29/2006 | EP1638557A2 Glycogen synthase kinase-3 inhibitors |
| 03/29/2006 | EP1587953A4 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 03/29/2006 | EP1551437A4 Methods and compositions for detecting cancers |
| 03/29/2006 | EP1511843B1 Screening methods |
| 03/29/2006 | EP1495329B1 Method for the identification of modulators of a secretase activity |
| 03/29/2006 | EP1487997A4 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 03/29/2006 | EP1478767B1 In vitro serological method of diagnosing infective endocarditis |
| 03/29/2006 | EP1470228B1 Detection of mutations |
| 03/29/2006 | EP1436086B1 Device for holding a substance library carrier |
| 03/29/2006 | EP1409666B1 Process for preparing variant polynucleotides |
| 03/29/2006 | EP1408118B1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase |
| 03/29/2006 | EP1402270B1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 03/29/2006 | EP1395677B1 Scintillation proximity assays for aminoglycoside binding molecules |
| 03/29/2006 | EP1373563B1 Method for detecting micro-organisms |
| 03/29/2006 | EP1358354B1 Method for identifying compounds modulating reverse cholesterol transport |
| 03/29/2006 | EP1346039B1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/29/2006 | EP1317545B1 Coryneform bacteria transformed with sequences encoding the PKND gene and their use in producing L-amino acids |
| 03/29/2006 | EP1305402B1 Lipo-viro-particle complexes, preparation method and uses |
| 03/29/2006 | EP1272676B1 Hiv detection assay and reagents therefor |
| 03/29/2006 | EP1268850B1 Fluorescence detection of proteases or peptidases |
| 03/29/2006 | EP1250451B1 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 03/29/2006 | EP1226279B1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 03/29/2006 | EP1226255B1 Compositions and methods utilizing dna polymerases |
| 03/29/2006 | EP1222467B1 Leptin assay based on detecting ang-2 expression |
| 03/29/2006 | EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues |
| 03/29/2006 | EP1208239B1 Method for detecting and quantifying first biopolymers that are located in a liquid |
| 03/29/2006 | EP1192467B1 Chemiluminescence redox assay to quantify analytes in biological samples |
| 03/29/2006 | EP1183541B1 Screening methods for altering circadian rhythm proteins |
| 03/29/2006 | EP1102782B1 Structural analogs of amine bases and nucleosides |
| 03/29/2006 | EP1086241B1 Non-viable cell preparation and assay reagent |
| 03/29/2006 | EP1062840B1 Apparatus and method for a custom soft-solid hearing aid |
| 03/29/2006 | EP1034302B1 De novo or "universal" sequencing array |
| 03/29/2006 | EP1012331B1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 03/29/2006 | EP1007627B1 Extracellular serine protease |
| 03/29/2006 | EP0965646B1 Probe for detecting and identifying helicobacter pylori |